MedicineEnvironmental Science

Andre K. Johnson, Zeron Ghazarian, Kristina Cendrowski, J. Persichino

2021.4.7Medical Mycology Case Reports

DOI: 10.1016/j.mmcr.2021.03.006

tlooto Summary

The first case of combined probable pulmonary aspergillosis and possible mucormycosis in a male with COVID-19 in the ICU is reported.

Abstract

Invasive pulmonary mucormycosis and aspergillosis are rare, life-threatening fungal infections. Most documented cases have been reported in patients with diabetes mellitus, neutropenia, or treatment with corticosteroids. Both infections have been recognized as secondary complications of COVID-19, especially among critically ill patients. We report the first case of combined probable pulmonary aspergillosis and possible mucormycosis in a male with COVID-19 in the ICU.

Citation format

JOHNSON, Andre K., et al. Pulmonary aspergillosis and mucormycosis in a patient with COVID-19. Medical Mycology Case Reports, 2021, 32: 64–67.